Transitional Coverage for Emerging Technologies
Article Publication Date
Summary
The Centers for Medicare & Medicaid Services (CMS) recently introduced the Transitional Coverage
for Emerging Technologies (TCET) pathway, a voluntary expedited Medicare coverage process for
certain FDA-designated Breakthrough Devices. This new pathway aims to support innovation while
ensuring faster and more consistent access to emerging medical technologies for Medicare
beneficiaries. The TCET pathway offers manufacturers increased pre-market engagement with CMS
and a high level of flexibility to address evidence gaps for coverage. This initiative seeks to develop
reliable evidence for informed healthcare decision-making and to ensure high-quality care for
Medicare beneficiaries.
for Emerging Technologies (TCET) pathway, a voluntary expedited Medicare coverage process for
certain FDA-designated Breakthrough Devices. This new pathway aims to support innovation while
ensuring faster and more consistent access to emerging medical technologies for Medicare
beneficiaries. The TCET pathway offers manufacturers increased pre-market engagement with CMS
and a high level of flexibility to address evidence gaps for coverage. This initiative seeks to develop
reliable evidence for informed healthcare decision-making and to ensure high-quality care for
Medicare beneficiaries.
Topics
Types/Tools
Programs/Initiatives
States
Keywords